Navigation Links
Outercurve Foundation Announces Contribution of .Net Bio Project
Date:10/18/2011

WAKEFIELD, Mass., Oct. 18, 2011 /PRNewswire/ -- The Outercurve Foundation today announced the acceptance of the .Net Bio project into the Research Accelerators Gallery. .Net Bio, a language-neutral, reusable .NET library and API that supports the development of applications for bioinformatics research, is the fourth project contributed to the gallery. The open source project, which has the support of bioinformatics researchers from a number of educational institutions, was contributed by Microsoft, the foundation's primary sponsor.

(Logo:  http://photos.prnewswire.com/prnh/20100928/NE72174LOGO)

The Research Accelerators Gallery hosts open source projects that support the development of tools and technologies used by academic researchers and scientists. Working within the gallery, .Net Bio contributors will be able to increase the project's focus on improving community development practices to broaden the capabilities and usefulness of .Net Bio to the life sciences community.

"The .Net Bio project shows the power of community and collaboration in the scientific and research communities," said Paula Hunter, Executive Director, Outercurve Foundation. "The contribution of such a significant and far-reaching project will help researchers expand participation in planned development engagements within the USA, Brazil, Colombia, and Australia. .Net Bio will enable researchers to share data and development methodologies to support a range of life sciences research projects."

.Net Bio, formerly known as the Microsoft Biology Foundation, is a bioinformatics toolkit that includes a library of commonly-used bioinformatics functions. The .Net Bio project's V1 release, completed in summer 2011, facilitates collaboration and accelerates scientific research by enabling different data sets to communicate. Several universities and corporations use .Net Bio tools to reduce processing time and enable scientists to focus on research. Project committers come from Cornell University, the University of Queensland, Johnson & Johnson, Illumina and Microsoft.

"As part of the Outercurve Foundation, .Net Bio project committers will have the resources and community participation to support more complex and very large plant genomes by working with universities and consortia around the world," said Tony Hey, Outercurve Board member and Corporate Vice President of Microsoft Research Connections. The project brings a strong history of consistent and dedicated community management to the Outercurve Foundation."

The Outercurve Foundation has three galleries and 17 projects. Galleries include the ASP.NET Open Source Gallery, the Research Accelerators Gallery and the Data, Language and System Interoperability (DLSI) Gallery.

For more information on the .Net Bio project, the Research Accelerators Gallery or the Outercurve Foundation please visit www.Outercurve.org.

About The Outercurve Foundation

The Outercurve Foundation is a not-for-profit foundation providing software IP management and project development governance to enable and encourage organizations to develop software collaboratively in open source communities for faster results.  The Outercurve Foundation is the only open source foundation that is platform, technology, and license agnostic. For more information about the Outercurve Foundation contact info@Outercurve.org.


'/>"/>
SOURCE Outercurve Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Kessler Foundation Appoints New Director of Human Performance and Engineering Laboratory
2. Major grant from the National Science Foundation will sustain UCSB materials research through 2017
3. Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy
4. Society of Interventional Radiology Foundation Funds Howard Hughes Medical Institute Award
5. Society of Interventional Radiology Foundation Welcomes Corporate Gift From Sirtex Medical
6. Parents Guide to Cord Blood Foundation Launches Nations First Searchable Map of U.S. Sites for Donating Umbilical Cord Blood
7. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
8. Metabolic Solutions Development Company Receives $773,000 From the Alzheimers Drug Discovery Foundation to Fund Phase 2a Trial
9. BIRD - Israel-US Binational Industrial R&D Foundation to Invest $8.1 Million in Nine New Projects
10. National Parkinson Foundation Awards More Than $1 Million for Research
11. Scientists Launch Vaccine Research Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... SAN DIEGO , Feb. 22, 2017  PrimeVax ... , will be presenting at the Annual Biocom Global ... on March 2, at 11:15 AM, at the Torrey ... are thankful to the organizers at Biocom who have ... this international symposium of biotechnology companies, investors, and clinical ...
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , the leading provider ... the world, is pleased to announce the launch of a new scholarship for young ... fields. , This merit-based scholarship is open to all high school seniors, 17 years ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... addition of Tom Perkins as European director. Operating from Pennside’s Zurich headquarters, Pennside ... , Perkins joins Pennside after more than a decade with leading market ...
(Date:2/21/2017)... ... 21, 2017 , ... During HIMSS 2017, CloudMine, a secure, ... a partnership with Redox, a leader in cloud-based healthcare integration and API services. ... keeping data secure in the cloud. , The digital health developers, and various ...
Breaking Biology Technology:
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
Breaking Biology News(10 mins):